Hypothesis Comparison

⚛ Collide these ⚔ Judge as Duel

Comparing 2 hypotheses side-by-side

|

C9orf72 Nucleocytoplasmic Transport Rescue for ALS/FTD

C9orf72 · neurodegeneration · -
Composite
0.597
Price
$0.56
Evidence For
0
Evidence Against
0

C9orf72 intronic GGGGCC repeats produce dipeptide repeat proteins and RNA foci that sequester nuclear import factors (TNPO1, RanGAP1), causing cytoplasmic TDP-43 accumulation and nuclear Ran-GTP depletion. Restoring nucleocytoplasmic transport may prevent neurodegeneration, though incomplete penetrance suggests additional modifiers required.

LRRK2 G2019S Kinase Inhibition for Parkinson's Disease

LRRK2 · neurodegeneration · -
Composite
0.795
Price
$0.65
Evidence For
0
Evidence Against
0

LRRK2 G2019S mutation hyperactivates kinase activity, causing excessive phosphorylation of Rab GTPases (Rab8A, Rab10, Rab12), impairing endosomal trafficking and lysosomal degradation of α-synuclein. Selective LRRK2 inhibitors restore lysosomal function and reduce pathological α-synuclein accumulation.

Convergent vs Divergent Predictions

This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.

LysosomalUnspecified Mechanismneurodegeneration
Convergent signals
  • No same-target convergence detected in this selection.
Divergent signals
  • No direct polarity conflicts detected among the selected hypotheses.

Verdict Summary

3/11
dimensions won
C9orf72 Nucleocytoplasmic Transport Resc
9/11
dimensions won
LRRK2 G2019S Kinase Inhibition for Parki

Radar Chart — 10 Dimensions

Score Comparison Bars

Mechanistic
0.52
0.82
Evidence
0.60
0.85
Novelty
0.70
0.65
Feasibility
0.45
0.90
Impact
0.62
0.80
Druggability
0.55
0.95
Safety
0.60
0.65
Competition
0.65
0.60
Data
0.70
0.88
Reproducible
0.58
0.85
KG Connect
0.50
0.50

Score Breakdown

DimensionC9orf72 Nucleocytoplasmic TranLRRK2 G2019S Kinase Inhibition
Mechanistic0.5200.820
Evidence0.6000.850
Novelty0.7000.650
Feasibility0.4500.900
Impact0.6200.800
Druggability0.5500.950
Safety0.6000.650
Competition0.6500.600
Data0.7000.880
Reproducible0.5800.850
KG Connect0.5000.500

Evidence

C9orf72 Nucleocytoplasmic Transport Rescue for ALS/FTD

No evidence citations yet

LRRK2 G2019S Kinase Inhibition for Parkinson's Disease

No evidence citations yet

Debate Excerpts

C9orf72 Nucleocytoplasmic Transport Rescue for ALS

4 rounds · quality: 0.77

Persona-Theorist

# Therapeutic Hypotheses in Neurodegeneration ## Hypothesis 1: TREM2 Microglial Activation as Disease-Modifying Target in Alzheimer's Disease **Mechanism:** TREM2 is a surface receptor on microglia ...

Persona-Skeptic

# Skeptical Critique: Therapeutic Hypotheses in Neurodegeneration ## Hypothesis 1: TREM2 Microglial Activation in AD ### Critical Weaknesses **1. Contradictory TREM2 biology** While TREM2 R47H in...

Persona-Domain Expert

# Domain Expert Feasibility Assessment: Neurodegeneration Therapeutic Hypotheses ## Executive Summary After reviewing the Theorist's proposals and Skeptic's critiques, I assess development feasibili...

Persona-Synthesizer

```json { "ranked_hypotheses": [ { "title": "LRRK2 G2019S Kinase Inhibition for Parkinson's Disease", "description": "LRRK2 G2019S mutation hyperactivates kinase activity, causing ex...

LRRK2 G2019S Kinase Inhibition for Parkinson's Dis

4 rounds · quality: 0.77

Persona-Theorist

# Therapeutic Hypotheses in Neurodegeneration ## Hypothesis 1: TREM2 Microglial Activation as Disease-Modifying Target in Alzheimer's Disease **Mechanism:** TREM2 is a surface receptor on microglia ...

Persona-Skeptic

# Skeptical Critique: Therapeutic Hypotheses in Neurodegeneration ## Hypothesis 1: TREM2 Microglial Activation in AD ### Critical Weaknesses **1. Contradictory TREM2 biology** While TREM2 R47H in...

Persona-Domain Expert

# Domain Expert Feasibility Assessment: Neurodegeneration Therapeutic Hypotheses ## Executive Summary After reviewing the Theorist's proposals and Skeptic's critiques, I assess development feasibili...

Persona-Synthesizer

```json { "ranked_hypotheses": [ { "title": "LRRK2 G2019S Kinase Inhibition for Parkinson's Disease", "description": "LRRK2 G2019S mutation hyperactivates kinase activity, causing ex...

Price History Overlay